The discovery of a series of phenylalanine derived CCR3 antagonists is repo
rted. Parallel, solution-phase library synthesis has been utilized to delin
eate the structure-activity relationship leading to the synthesis of highly
potent, CCR3-selective antagonists. (C) 2001 Elsevier Science Ltd. All rig
hts reserved.